PepGen PEPG
NASDAQ PEPG
$3.11 -0.07 (-2.20%)
As of: Sep 4, 2026 · 3:59 PM EDT

PepGen (PEPG) Other Non-Current Assets (2021 - 2026)

PepGen (PEPG) posted Other Non-Current Assets of $389000.0 for Q1 2026, down 74.87% sequentially from $1.5 million in Q4 2025, and down 74.87% YoY from $1.5 million in Q1 2025.

Analysis

PepGen (PEPG) Other Non-Current Assets (2021 - 2026) Analysis & Trends

PepGen has reported Other Non-Current Assets for 6 years, with the latest figure at $389000.0 in Q1 2026.

  • Quarterly Other Non-Current Assets fell 74.87% year-over-year to $389000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $389000.0 (down 74.87% YoY) and the FY2025 annual result came in at $1.5 million, changed 0.0% from the prior year.
  • Other Non-Current Assets slipped to $389000.0 in Q1 2026 per PEPG's latest filing, from $1.5 million in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $3.6 million in Q1 2022 and troughed at $372000.0 in Q3 2025.
  • A 5-year average of $1.5 million and a median of $1.5 million in 2023 frame the typical range for Other Non-Current Assets.
  • The sharpest annual moves came in 2023 and 2025: Other Non-Current Assets gained 15.55% in 2023, then slumped 75.97% in 2025.
  • Over 5 years, Other Non-Current Assets stood at $1.5 million in 2022, then grew by 5.09% to $1.5 million in 2023, then changed by 0.0% to $1.5 million in 2024, then changed by 0.0% to $1.5 million in 2025, then tumbled by 74.87% to $389000.0 in 2026.
  • According to Business Quant data, Other Non-Current Assets over the past three periods registered $389000.0, $1.5 million, and $372000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 2.31 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 124.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 618.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 42.45 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 109.58 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 65.13 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 62.96 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 104.44 Mn
10 PepGen 217.99 Mn 217.99 Mn - 1.55 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.55 Mn
Mar 31, 2026 1.55 Mn
Dec 31, 2025 1.55 Mn
Sep 30, 2025 1.55 Mn
Jun 30, 2025 1.55 Mn
Mar 31, 2025 1.55 Mn
Dec 31, 2024 1.55 Mn
Sep 30, 2024 1.55 Mn
Jun 30, 2024 1.55 Mn
Mar 31, 2024 1.55 Mn
Dec 31, 2023 1.55 Mn
Sep 30, 2023 1.55 Mn
Jun 30, 2023 1.70 Mn
Mar 31, 2023 1.47 Mn
Dec 31, 2022 1.47 Mn
Sep 30, 2022 1.47 Mn
Jun 30, 2022 1.47 Mn
Mar 31, 2022 3.64 Mn
Dec 31, 2021 3.02 Mn